 NEW YORK and VIENNA, Sept. 07, 2022 GLOBE NEWSWIRE -- HOOKIPA Pharma Inc. NASDAQ: HOOK, HOOKIPA, a company developing a new class of immunotherapies based on its proprietary arenavirus platform, today announced that HOOKIPAs management team will participate in the following upcoming investor conferences: 